https://na-sj04.marketodesigner.com/m?explictHostname=app-sj04.marketo.com#LPTE5875 Avitene™ Microfibrillar Collagen Hemostat












THE DIFFERENCE IS

PUTTING PRECISION
TO WORK


Clinical Study:
AviteneTM  Microfibrillar Collagen Hemostat for
Adjunctive Hemostasis in Surgical Procedures:
A Systematic Literature Review

Avitene™ Ultrafoam™ in a craniotomy procedure


Dr. Angela Bohnen, MD
NeurosurgeryOne
Denver, CO

Avitene™ MCH in a craniotomy procedure

Dr. Angela Bohnen, MD
NeurosurgeryOne
Denver, CO

Experts from around the globe describe the intersection between patient and healthcare worker safety, focusing on techniques to improve both occupational and public health.

Webinar Objectives:

  • Describe the current global impact of bloodborne disease
  • Describe occupational exposure incidents for needlesticks and sharps injuries
  • Define safety as a function of focus for both patient and health worker, to reduce overall bloodborne disease
  • Provide guidance on the importance of prevention programs including use of safer medical devices, immunization/vaccination programs, and safe clinical practices
  • Illustrate an effective pathway for reporting exposure incidents and injuries
  • Define processes for post-exposure medical treatment and prophylaxis
  • Share global experiences from key stakeholders responsible for sharps safety and public health programs around the world

Save Your Seat


Avitene™ Microfibrillar Collagen Hemostat

Approved for use in neurosurgery





Clinical Data

Read
the Avitene™ 
Clinical Publication
Summary

Read Now


Neuro Brochure

Access our neuro brochure
to further understand how
Avitene™ performs in neurosurgery.

Download brochure


Education

Learn more about our online resources for hemostat education

Learn More





Repairs

The open monofilament mesh structure provides early integration and repair strength.3





Remodels

Vascular integration and incorporation continues, with abundant mature collagen at 52 weeks. Gradually transfers load to native tissue over time.3





Restores

As Phasix™ Mesh is remodeled, it is replaced with functional tissue, ultimately resulting in a strong repair at one year.3

Video title here

Play

Avitene™ UltraFoam™ Collagen Sponge

Soft, pliable and ready to use out of the package without soaking or waste.2,8 Available in 3 mm, 7 mm, and 10 mm thickness options which may be cut and shaped to suit your needs.2,13

Avitene™ Microfibrillar Collagen Hemostat

A soft, fluffy, mouldable form of microfibrillar collagen which is effective in controlling arterial hemorrhage.11 It conforms and adheres to irregular spaces and it’s easy to remove with gentle irrigation if needed.11,12

Avitene™ Sheets

Composed of non-woven Avitene™ collagen fibrils in a sheet form which may be cut into any shape or size, the sheet clings tenaciously to the bleeding point.2,8

SyringeAvitene™ Applicators

Pre-filled syringe designed for use in trauma, oncology, general and cardiovascular surgery

Let's have a conversation















Rapid tissue incorporation 1



Organized and functional collagen at the repair site1



4x the strength of the native abdominal wall at 24 weeks in preclinical testing1

Placeholder

Pellentesque habitant morbi

  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada

Placeholder

Pellentesque habitant morbi

  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada
  • Tristique senectus et netus et malesuada

Placeholder

Predictable strength for the long run

  • Long-term strength with no permanent material left behind2,3
  • Organized and functional collagen at the repair site3

Placeholder

Predictable strength for the long run

  • Long-term strength with no permanent material left behind2,3
  • Over 2x the strength of other bioresorbable mesh3
  • Predictable resorption time3
  • Minimizes risk of tissue attachment3

Store Tab

360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.

360° rotation knob is effectively sized

360° rotation knob is effectively sized

360° rotation knob is effectively sized

More product details

Resources and education

Hospitals and healthcare facilities

BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.

Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>

Hospitals and healthcare facilities

BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.

Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>

Avitene™ MCH is a simple, safe, effective and easy to use hemostat to control bleeding during surgery.1,2 Unlike many alternatives, such as bovine gelatin and oxidized regenerated cellulose (ORC), Avitene™ does not swell after implantation, so will not cause delayed compression in confined areas where small vessels, nerves or other delicate structures are present.2,3,6,7

E-learning courses

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

User group webcasts

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Let's have a conversation

E-learning courses
User group webcasts

Let's have a conversation

E-learning courses
User group webcasts

Let's have a conversation



Mesh selection matters

8%

In a study with
Dr. Steven DeMeester,
Phasix™ ST Mesh is associated with an
8% recurrence rate at a median follow-up of
12 months1

42%

Dr. Carlos Galvani
utilized Gore Bio-A®
and reported a 42% recurrence rate at a median follow-up of
24 months4

56%

In a randomized controlled study,
Cook Surgisis® (Biodesign®) is associated with a
56% recurrence rate at a median follow-up of
58 months5



Let's have a conversation
REFERENCES

1. Fujimoto Y, Kobayashi T, Komori M, et al. Modified hemostatic technique using microfibrillar collagen hemostat in endoscopic endonasal transsphenoidal surgery: technical note neurol med chir (Tokyo). 2014;54(8): 617–621. 2. Avitene™ Instructions For Use. 3. BD Data on file. 4. Palm MD, Altman JS. Topical hemostatic agents: a review. Dermatol Surg. 2008;34(4):431-445. 5. Sundaram CP, Keenan AC. Evolution of hemostatic agents in surgical practice. Indian J Urol. 2010;26(3):374–378. 6. Apel -Sarid L, Cochrane DD, Steinbok P, et al. Microfibrillar collagen hemostat–induced necrotizing granulomatous inflammation developing after craniotomy: a pediatric case series: Report of 3 cases. J Neurosurgery 2010;6(4):385-392. 7. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;13(Suppl 1):S89-96. 8. US Avitene™ Brochure HP198310-3. 9. Schreiber MA, Neveleff DJ. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J. 2011;94(5):S1-20. 10. Qerimi B, Baumann P, Hüsing J, Knaebel HP, Schumacher H. Collagen hemostat significantly reduces time to hemostasis compared with cellulose: COBBANA, a single-center, randomized trial. Am J Surg. 2013;205(6):636-641. 11. Abbott WM, Austen WG. The effectiveness and mechanism of collagen-induced topical hemostasis. Surgery. 1975;78(6):723-729. 12. Avitene™ Ultrafoam™ Instruction For Use. 13. Vyas KS, Saha SP. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther. 2013;13(12):1663-1672. 14. Sirlak M, Eryilmaz S, Yazicioglu L, et al. Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery. J Thorac Cardiovasc Surg. 2003;126(3):666-670. 15. Lee IY, Sawaya R, Levine NB. Intraoperative non-hematologic adjuvant methods for preventing blood loss. https:// neupsykey.com/intraoperative-non-hematologic-adjuvantmethods-for-preventing-blood-loss. Published Jul 11, 2016. Accessed June 7, 2019. 16. FloSeal Instructions For Use.

Indications: Avitene™ Microfibrillar Collagen Haemostat (MCH) and Avitene™ UltraFoam™ sponge are used in surgical procedures as an adjunct to haemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical. Contraindications: Avitene™ MCH and Avitene™ UltraFoam™ sponge should not be used in the closure of skin incisions as it may interfere with the healing of the skin edges. This is due to simple mechanical interposition of dry collagen and not to any intrinsic interference with wound healing. It has been reported with other collagen haemostatic agents, that by filling porosities of cancellous bone, they may significantly reduce the bond strength of methylmethacrylate adhesives. Avitene™ MCH and Avitene™ UltraFoam™ sponge should not, therefore, be employed on bone surfaces to which prosthetic materials are to be attached with methylmethacrylate adhesives. Warnings: Avitene™ MCH and Avitene™ UltraFoam™ sponge are inactivated by autoclaving. Ethylene oxide reacts with bound hydrochloric acid to form ethylene chlorohydrin. These devices have been designed for single use only. Reuse, reprocessing, resterilisation or repackaging may compromise the structural integrity and/or essential material and design characteristics that are critical to the overall performance of the device and may lead to device failure which may result in injury to the patient. Reuse, reprocessing, resterilisation or repackaging may also create a risk of contamination of the device and/or cause patient infection or cross infection, including, but not limited to, the transmission of infectious diseases from one patient to another. Contamination of the device may lead to injury, illness or death of the patient or end user. Opened, unused product should be discarded. Moistening Avitene™ MCH and Avitene™ UltraFoam™ sponge or wetting with saline or thrombin impairs its haemostatic efficacy. It should be used dry. As with any foreign substance, use of Avitene™ MCH and Avitene™ UltraFoam™ sponge in contaminated wounds may enhance infection. Avitene™ UltraFoam™ sponge should not be used in instances of pumping arterial haemorrhage. Avitene™ UltraFoam™ sponge should not be used where blood or other fluids have pooled, or in cases where the point of haemorrhage is submerged as it may mask an underlying source of bleeding, resulting in haematoma. Avitene™ UltraFoam™ sponge is not intended to treat systemic coagulation disorders. Avitene™ MCH and Avitene™ UltraFoam™ sponge are not for injection, intraocular or intravascular use. Adverse reactions: The most serious adverse reactions reported which may be related to the use of Avitene™ MCH or other collagen products are potentiation of infection including abscess formation, haematoma, wound dehiscence and mediastinitis. Other reported adverse reactions possibly related are adhesion formation, allergic reaction, foreign body reaction and subgaleal seroma (report of a single case) and increased the incidence of alveolalgia when used for packing of dental extraction sockets. Transient laryngospasm due to aspiration of dry material has been reported following use of Avitene™ MCH in tonsillectomy. Please consult packaging insert for more detailed safety information and instructions for use.

BD-42275


BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.

Contact us | Unsubscribe | My profile

© BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.

Privacy Policy | Terms of Use